Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
08/2012
08/22/2012CN101792783B Preparation method and application of banana natural resistant starch RS2
08/22/2012CN101766812B Liquid drug combination containing exenatide or analogues thereof
08/22/2012CN101711582B Composition containing American ginseng extract and probiotics and application thereof
08/22/2012CN101703449B Method for preparing fluorine-contained photo-curing nano compound resin dental materials
08/22/2012CN101560246B Thymopentin derivate, preparation method and application of derivate and compound containing derivate in preparing drugs
08/22/2012CN101310768B Medicine composition for treating hepatic disease and use thereof
08/22/2012CN101259140B Compound medicaments treating gastritis, gastric ulcer, and duodenal ulcer and preparation thereof
08/22/2012CN101088523B Nanometer solid lipid particle of active skullcap components and its prepn process and prepn
08/22/2012CN101076349B Application of stimulating the motility of the gastrointestinal system using growth hormone secretagogues
08/21/2012US8247432 Tripeptidyl peptidase inhibitors
08/21/2012US8247403 Benzoxazepine derivatives and use thereof
08/21/2012US8246951 Collagenolytic active enzyme containing compositions, and their use in the dental field
08/21/2012US8246930 Multicomponent assemblies having enhanced binding properties for diagnosis and therapy
08/21/2012CA2540730C Alfavbeta3 and alfavbeta6 integrin antagonists as antifibrotic agents
08/21/2012CA2469490C Method of preparing delta-9 tetrahydrocannabinol
08/21/2012CA2469076C Pharmaceutical compositions comprising dihydropyridinone compounds and an immunoregulatory or an antiinflammatory agent and their uses
08/21/2012CA2251576C Glucagon-like peptide-2 analogs
08/16/2012WO2012109605A2 Forms of rifaximin and uses thereof
08/16/2012WO2012108830A1 Synbiotic compositions for restoration and reconstitution of gut microbiota
08/16/2012WO2012108518A1 Bacteriocin derived from lactobacillus rhamnosus
08/16/2012WO2012108478A1 Monocyclic compound
08/16/2012WO2012107918A1 A cola beverage containing inula viscosa extract for consumers suffering non-alcoholic fatty liver disease (nafld)
08/16/2012WO2012107769A1 Treatment of allergic disorders
08/16/2012WO2012107455A1 Galactofructose for the regulatory effect thereof on intestinal transit
08/16/2012WO2012091357A3 Composition for prevention of nausea or vomiting
08/16/2012WO2012078746A9 Compositions and methods for mobilizing stem cells
08/16/2012WO2012073245A8 Conjugates of a phospholipid and a drug for the treatment of inflammatory bowel disease
08/16/2012US20120210451 Islet cell sheet, process for production thereof, and use thereof
08/16/2012US20120209050 Novel pyridopyrazine derivatives, process of manufacturing and uses thereof
08/16/2012US20120208900 Methods of predicting the need for surgery in crohn's disease
08/16/2012US20120208899 Tool for Assessment of Symptoms of Irritable Bowel Syndrome
08/16/2012US20120208892 Emesis treatment
08/16/2012US20120208889 Class- and isoform-specific hdac inhibitors and uses thereof
08/16/2012US20120208885 L-ornithine phenyl acetate and methods of making thereof
08/16/2012US20120208878 Medical composition
08/16/2012US20120208852 Heterocyclic-substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof
08/16/2012US20120208850 Methods, compounds, and compositions for delivering 1,3-propanedisulfonic acid
08/16/2012US20120208841 Modulators of Cystic Fibrosis Transmembrane Conductance Regulator
08/16/2012US20120208836 Compositions and methods for the treatment of obesity and related disorders
08/16/2012US20120208822 Pyrimido-pyrrolo-quinoxalinedione inhibitors of cystic fibrosis transmembrane conductance regulator protein and uses therefor
08/16/2012US20120208812 DISUBSTITUTED OCTAHYDROPYRROLO[3,4-c]PYRROLES AS OREXIN RECEPTOR MODULATORS
08/16/2012US20120208808 Pyrazolopyrimidine derivatives
08/16/2012US20120208799 Compounds
08/16/2012US20120208793 Thieno- and furo-pyrimidine modulators of the histamine h4 receptor
08/16/2012US20120208790 Ion channel modulators and methods of use
08/16/2012US20120208785 Prodrugs of 2,4-Pyrimidinediamine Compounds and Their Uses
08/16/2012US20120208782 Modulation of Growth of Bifidobacteria Using a Combination of Oligosaccharides Found in Human Milk
08/16/2012US20120208777 Diosmetin compounds, a process for their preparation and pharmaceutical compositions containing them
08/16/2012US20120208750 Use of protein kinase c delta (pkcd) inhibitors to treat diabetes, obesity, and hepatic steatosis
08/16/2012US20120208743 Use of gelsolin to diagnose and treat inflammatory diseases
08/16/2012US20120208260 Novel lactobacillus plantarum and composition comprising the same
08/16/2012US20120207854 Metal polysulfide-complex with biological and chemical activity
08/16/2012US20120207842 Multiparticulate l-menthol formulations and related methods
08/16/2012US20120207834 Oral antimicrobial pharmaceutical compositions
08/16/2012US20120207833 Forms of rifaximin and uses thereof
08/16/2012US20120207832 Forms of rifaximin and uses thereof
08/16/2012US20120207773 Materials and methods for the development of an antigen-specific immune non-responsiveness state
08/16/2012US20120207761 Anti-il-22ra antibodies and binding partners and methods of using in inflammation
08/16/2012US20120207745 Composition to Induce Specific Immune Tolerance
08/16/2012US20120207741 Enzymes For Pharmaceutical Use
08/16/2012US20120207740 Method for Treating Pervasive Development Disorders
08/16/2012US20120207737 Medical utility of glycan-binding proteins and glycans
08/16/2012US20120207726 Autism-associated biomarkers and uses thereof
08/16/2012US20120207725 Mesenchymal stem cell incorporating a nucleotide sequence coding tgfb, and uses thereof
08/16/2012US20120207713 Probiotic bifidobacterium strains
08/16/2012US20120207712 Compositions Comprising Probiotic and Prebiotic Components and Mineral Salts, with Lactoferrin
08/16/2012US20120207710 Nutritional supplement to improve supplementary target protein fraction (tpf) delivery, intracellular absorption and utilization
08/16/2012CA2825964A1 Forms of rifaximin and uses thereof
08/15/2012EP2487178A1 Pyrazolothiazole compound
08/15/2012EP2487177A1 Pyrazoloxazole compound
08/15/2012EP2486943A1 Pharmaceutical composition for the prophylaxis and treatment of infectious and non-infectious diarrhoea
08/15/2012EP2486935A1 Epitopes related to Coeliac Disease
08/15/2012EP2486934A1 Epitopes Related To Coeliac Disease
08/15/2012EP2486143A1 Methods for diagnosing irritable bowel syndrome
08/15/2012EP2485756A2 Glp-2 for use in intestine and muscle recovery
08/15/2012EP2170930B1 Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
08/15/2012EP2030628B1 A peptide for preventing or treating liver damage and its derivant and the use
08/15/2012EP1696734B1 Methods and kits related to administration of a fructooligosaccharide
08/15/2012EP1438295B1 Azole derivatives and pharmaceutical compositions containing them
08/15/2012EP1420716B1 An implantable and sealable system for unidirectional delivery of therapeutic agents to targeted tissues
08/15/2012EP1379242B1 Method for treatment of cancer and compositions for use therein
08/15/2012EP1294391B1 Combination of agents for inhibiting transplant rejection
08/15/2012CN1976938B Thienopyrazole derivative having PDE7 inhibitory activity
08/15/2012CN102639513A Sphingosine kinase inhibitors
08/15/2012CN102639138A Composition for preventing or treating liver toxicity, including arrowroot extract or a fermented arrowroot extract/lactobacillus compound as an active ingredient
08/15/2012CN102639130A Methods and compositions for treating disease or condition related to orexin receptor 1, orexin receptor 2, somatostatin receptor 2 or dopamine d2l receptor
08/15/2012CN102634439A Shanxi vinegar
08/15/2012CN102634432A Desert cistanche and black rice health maintenance wine and production method thereof
08/15/2012CN102633874A Chemical coupling matter of deletion-recombination human keratinocyte growth factor I type
08/15/2012CN102633832A Method for preparing high-purity phosphatidylcholine
08/15/2012CN102633760A Isofraxidin crystalline compound and glabrous sarcandra herb dispersible tablets and dropping pills containing isofraxidin crystalline compound
08/15/2012CN102633730A Substituted piperazines as cb1 antagonists
08/15/2012CN102633716A Bicyclic inhibitors of mek and methods of use thereof
08/15/2012CN102633637A Pharmaceutical formula for effectively relieving and treating constipation
08/15/2012CN102631662A Composition with functions of protecting liver and relieving fatigue and preparation method of composition
08/15/2012CN102631660A Chinese medicament for treating intestinal obstruction
08/15/2012CN102631659A Traditional Chinese medicine for treating infantile diarrhea and preparation method of traditional Chinese medicine
08/15/2012CN102631652A Preparation method for traditional Chinese medicine for treating spleen deficiency type colitis
08/15/2012CN102631651A Method for preparing traditional Chinese medicine (TCM) for treating night sweat type colitis
08/15/2012CN102631650A Method for preparing traditional Chinese medicine (TCM) for treating cold-sensitive colitis
1 ... 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 ... 1258